YS BIOPHARMA CO LTD (YS) Stock Analyst Earnings Estimates
NASDAQ:YS - Nasdaq - KYG9845F1090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 687.201M | 88.632M -87.10% | 112.79M 27.26% | 197.57M 75.17% | 1.88B 851.56% | 2.067B 9.95% | 2.538B 22.79% | |||
| EBITDA YoY % growth | N/A | 30.597M | -102.695M -435.63% | -22.739M 77.86% | -1.352M 94.05% | 16.108M 1,291.25% | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.64K | -556.83K -15,197.53% | -139.382M -24,931.40% | -27.919M 79.97% | -6.768M 75.76% | 15.235M 325.11% | 537.75M 3,429.70% | 683.32M 27.07% | 1.038B 51.91% | |
| Operating Margin | N/A | N/A | -20.28% | -31.50% | -6.00% | 7.71% | 28.60% | 33.06% | 40.90% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.34 | -0.11 66.94% | 0.04 132.93% | N/A | N/A | N/A |
All data in CNY
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 | -0.70 | -0.37 67.19% | -0.29 65.25% | -0.06 89.66% |
| Revenue Q2Q % growth | 162.81M -76.31% | 181.09M | 186.76M 92.90% | 203.81M 23.54% | 232.54M 42.83% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -50.926M 63.46% | N/A | N/A | N/A | N/A |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.83 | -0.59 | -0.24 | -41.37% |
| Q2 2024 Q2Q % growth | -1.13 | -0.74 | -0.39 | -52.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 164.977M | 147.04M | 17.937M | 12.20% |
| Q2 2024 Q2Q % growth | 96.816M | 149.52M | -52.704M | -35.25% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 26.45% | 0% | 0% |
| Revenue | 0% | 0.98% | 0% | -85.12% |